160 related articles for article (PubMed ID: 33116585)
21. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
[TBL] [Abstract][Full Text] [Related]
22. GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma.
Xue Y; Wu G; Liao Y; Xiao G; Ma X; Zou X; Zhang G; Xiao R; Wang X; Liu Q; Long D; Yang J; Xu H; Liu F; Liu M; Xie K; Huang R
Br J Cancer; 2014 Apr; 110(9):2250-60. PubMed ID: 24595000
[TBL] [Abstract][Full Text] [Related]
23. Targeted p21(WAF1/CIP1) activation by miR-1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma.
Wang C; Tang K; Li Z; Chen Z; Xu H; Ye Z
Urol Oncol; 2016 Feb; 34(2):59.e23-34. PubMed ID: 26421587
[TBL] [Abstract][Full Text] [Related]
24. Control of the DNA methylation system component MBD2 by protein arginine methylation.
Tan CP; Nakielny S
Mol Cell Biol; 2006 Oct; 26(19):7224-35. PubMed ID: 16980624
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic miR-663a is associated with cellular function and poor prognosis in renal cell carcinoma.
Zhou L; Pan X; Li Z; Chen P; Quan J; Lin C; Lai Y; Xu J; Xu W; Guan X; Li H; Gui Y; Lai Y
Biomed Pharmacother; 2018 Sep; 105():1155-1163. PubMed ID: 30021352
[TBL] [Abstract][Full Text] [Related]
26. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
Lin H; Zeng W; Lei Y; Chen D; Nie Z
Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
28. MBD2 facilitates tumor metastasis by mitigating DDB2 expression.
Zhang L; Wang S; Wu GR; Yue H; Dong R; Zhang S; Yu Q; Yang P; Zhao J; Zhang H; Yu J; Yuan X; Xiong W; Yang X; Yong T; Wang CY
Cell Death Dis; 2023 May; 14(5):303. PubMed ID: 37142578
[TBL] [Abstract][Full Text] [Related]
29. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
[TBL] [Abstract][Full Text] [Related]
30. Cytoplasmic expression of pontin in renal cell carcinoma correlates with tumor invasion, metastasis and patients' survival.
Zhang X; Ren J; Yan L; Tang Y; Zhang W; Li D; Zang Y; Kong F; Xu Z
PLoS One; 2015; 10(3):e0118659. PubMed ID: 25751257
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
32. LncRNA POU3F3 Promotes Cancer Cell Proliferation, Migration, and Invasion in Renal Cell Carcinoma by Downregulating LncRNA GAS5.
Zhang L; Wang C; Ma M
Kidney Blood Press Res; 2021; 46(5):613-619. PubMed ID: 34352801
[TBL] [Abstract][Full Text] [Related]
33. Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells.
Devailly G; Grandin M; Perriaud L; Mathot P; Delcros JG; Bidet Y; Morel AP; Bignon JY; Puisieux A; Mehlen P; Dante R
Nucleic Acids Res; 2015 Jul; 43(12):5838-54. PubMed ID: 26007656
[TBL] [Abstract][Full Text] [Related]
34. Trim24 prompts tumor progression via inducing EMT in renal cell carcinoma.
Jiang T; Mao H; Chen Q; Cao L; He Y; Gao X; Chen W; Zhang H
Open Med (Wars); 2020; 15(1):1153-1162. PubMed ID: 33336072
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of CAPN2 promotes cell metastasis and proliferation via AKT/mTOR signaling in renal cell carcinoma.
Miao C; Liang C; Tian Y; Xu A; Zhu J; Zhao K; Zhang J; Hua Y; Liu S; Dong H; Zhang C; Su S; Li P; Qin C; Wang Z
Oncotarget; 2017 Nov; 8(58):97811-97821. PubMed ID: 29228653
[TBL] [Abstract][Full Text] [Related]
36. Feline sarcoma-related protein expression correlates with malignant aggressiveness and poor prognosis in renal cell carcinoma.
Miyata Y; Kanda S; Sakai H; Greer PA
Cancer Sci; 2013 Jun; 104(6):681-6. PubMed ID: 23445469
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of flotillin-2 is associated with renal cell carcinoma progression.
Yan Y; Yang FQ; Zhang HM; Che J; Zheng JH
Tumour Biol; 2014 Oct; 35(10):10479-86. PubMed ID: 25053596
[TBL] [Abstract][Full Text] [Related]
38. miR-638 acts as an oncogene and predicts poor prognosis in renal cell carcinoma.
Pan X; He T; Peng X; Li H; Zhang F; Lai Y
Am J Transl Res; 2020; 12(7):3645-3659. PubMed ID: 32774724
[TBL] [Abstract][Full Text] [Related]
39. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
